Ythdf3-flox 基因敲除小鼠

下单100%中奖,最高可得千元京东卡
复苏/繁育服务
产品名称

Ythdf3-flox 基因敲除小鼠

产品编号

S-CKO-07230

品系全称

C57BL/6NCya-Ythdf3em1flox/Cya

品系背景

C57BL/6NCya

品系编号

CKOCMP-229096-Ythdf3-B6N-VA

品系状态

使用本品系发表的文献需注明: Ythdf3-flox 基因敲除小鼠 mice (Strain S-CKO-07230) were purchased from Cyagen.
交付类型
周龄
性别
基因型
数量
cKO小鼠库模型

基本信息

基因研究概述

质控标准

基因
基因全称
YTH N6-methyladenosine RNA binding protein 3
基因别称
9130022A11Rik
染色体号
Chr 3 (Mouse)
转录本 ID
NCBI: NM_172677 | Ensembl: ENSMUST00000108346
修饰方式
条件性基因敲除
靶向范围
Exon 3
敲除长度
~2.3 kb
品系说明
该品系是基于策略设计时的数据库信息制作而成,建议您在购买前查询最新的数据库和相关文献,以获取最准确的表型信息。
表型提示
MGI:1918850Mice homozygous for a knock-out allele exhibit decreased susceptibility to vesicular stomatitis virus (VSV) infection. Homozygous KO does not affect viability or fertility.
YTHDF3,也称为YTH domain family 3,是一种在哺乳动物细胞中发现的RNA结合蛋白,属于YTH结构域家族。YTHDF3是N6-甲基腺苷(m6A)修饰的识别器,参与调控RNA的代谢和功能。m6A是一种在真核细胞RNA上普遍存在的表观遗传修饰,由甲基转移酶复合物催化生成,包括METTL3、METTL14和WTAP等。m6A修饰在RNA的稳定性和功能调控中发挥着重要作用,影响基因表达和多种生物学过程。

YTHDF3在多种癌症中发挥重要作用,包括乳腺癌、胰腺癌、结直肠癌、胃癌和前列腺癌。YTHDF3通过识别m6A修饰的RNA,促进其翻译或降解,从而影响肿瘤细胞的行为和肿瘤的进展。例如,在乳腺癌中,YTHDF3的表达与脑转移相关,YTHDF3通过促进癌细胞与脑微环境的相互作用,增强脑转移的能力[1]。在胰腺癌中,YTHDF3的表达与不良预后相关,YTHDF3通过S-palmitoylation稳定MYC mRNA,从而促进肿瘤的进展[3]。在结直肠癌中,YTHDF3的表达与不良预后相关,YTHDF3通过促进lncRNA GAS5的降解,激活YAP信号通路,从而促进肿瘤的进展[6]。在胃癌中,YTHDF3的表达与不良预后相关,YTHDF3通过激活PI3K/AKT信号通路和调节免疫微环境,促进肿瘤的生长和侵袭[9]。在前列腺癌中,YTHDF3的表达与不良预后相关,YTHDF3通过调节m6A修饰的RNA的降解和稳定性,促进肿瘤的进展[10]。

YTHDF3除了在癌症中发挥作用外,还在其他生物学过程中发挥作用,例如自噬和细胞应激反应。YTHDF3通过识别m6A修饰的FOXO3 mRNA,促进其翻译,从而诱导自噬的发生[2]。YTHDF3的表达水平受到多种因素的调控,包括基因拷贝数、转录调控和蛋白质翻译后修饰。YTHDF3的蛋白质翻译后修饰,如O-GlcNAcylation,可以影响其功能[7]。YTHDF3的相变特性可以影响其与RNA的结合和功能[8]。

综上所述,YTHDF3是一种重要的m6A识别器,参与调控RNA的代谢和功能,影响基因表达和多种生物学过程。YTHDF3在多种癌症中发挥重要作用,通过促进肿瘤细胞的行为和肿瘤的进展,影响肿瘤的发生和发展。YTHDF3的研究有助于深入理解m6A修饰的生物学功能和疾病发生机制,为疾病的治疗和预防提供新的思路和策略。

参考文献:
1. Chang, Guoqiang, Shi, Lei, Ye, Youqiong, He, Chuan, Huang, Suyun. 2020. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. In Cancer cell, 38, 857-871.e7. doi:10.1016/j.ccell.2020.10.004. https://pubmed.ncbi.nlm.nih.gov/33125861/
2. Hao, WeiChao, Dian, MeiJuan, Zhou, Ying, Sun, Yan, Xiao, Dong. 2022. Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA. In Nature communications, 13, 5845. doi:10.1038/s41467-022-32963-0. https://pubmed.ncbi.nlm.nih.gov/36195598/
3. Zhang, Huan, Sun, Yan, Wang, Zhaokai, Jiang, Ke, Jin, Xin. 2024. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. In Nature communications, 15, 4642. doi:10.1038/s41467-024-49105-3. https://pubmed.ncbi.nlm.nih.gov/38821916/
4. Murakami, Shino, Jaffrey, Samie R. . Hidden codes in mRNA: Control of gene expression by m6A. In Molecular cell, 82, 2236-2251. doi:10.1016/j.molcel.2022.05.029. https://pubmed.ncbi.nlm.nih.gov/35714585/
5. Deng, Changmi, Han, Yufeng, Zhou, Haixia, Hua, Rui-Xi, Fu, Wen. 2024. YTHDF3 gene polymorphisms increase Wilms tumor risk in Chinese girls. In Journal of Cancer, 15, 6103-6109. doi:10.7150/jca.99928. https://pubmed.ncbi.nlm.nih.gov/39440064/
6. Ni, Wen, Yao, Su, Zhou, Yunxia, Che, Liheng, Li, Jianming. 2019. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. In Molecular cancer, 18, 143. doi:10.1186/s12943-019-1079-y. https://pubmed.ncbi.nlm.nih.gov/31619268/
7. Chen, Yulin, Wan, Ruixi, Zou, Zhongyu, He, Chuan, Lin, Shixian. 2023. O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins. In Nature cell biology, 25, 1676-1690. doi:10.1038/s41556-023-01258-x. https://pubmed.ncbi.nlm.nih.gov/37945829/
8. Dai, Chenyun, Cao, Jianfu, Tang, Yuangui, Luo, Chenghua, Zheng, Junfang. 2024. YTHDF3 phase separation regulates HSPA13-dependent clear cell renal cell carcinoma development and immune evasion. In Cancer science, 115, 2588-2601. doi:10.1111/cas.16228. https://pubmed.ncbi.nlm.nih.gov/38811341/
9. Yu, Yi, Meng, Li-Li, Chen, Xiao-Yu, Zhang, Jing, Zhu, Jin-Shui. 2023. m6A reader YTHDF3 is associated with clinical prognosis, related RNA signatures and immunosuppression in gastric cancer. In Cellular signalling, 108, 110699. doi:10.1016/j.cellsig.2023.110699. https://pubmed.ncbi.nlm.nih.gov/37149073/
10. Duan, Juanjuan, Fan, Daogui, Chen, Pingping, Yu, Wenfeng, Zhang, Qifang. . YTHDF3 Regulates the Degradation and Stability of m6A-Enriched Transcripts to Facilitate the Progression of Castration-Resistant Prostate Cancer. In Journal of pineal research, 76, e13003. doi:10.1111/jpi.13003. https://pubmed.ncbi.nlm.nih.gov/39143673/